These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19424698)

  • 41. Clinical and genetic characterization of Italian patients affected by CINCA syndrome.
    Caroli F; Pontillo A; D'Osualdo A; Travan L; Ceccherini I; Crovella S; Alessio M; Stabile A; Gattorno M; Tommasini A; Martini A; Lepore L
    Rheumatology (Oxford); 2007 Mar; 46(3):473-8. PubMed ID: 16920754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Case of Amyloidosis Caused by Sporadic Muckle-Wells Syndrome: Response to Treatment With Anakinra.
    İlgen U; Küçükşahin O; Erdoğmuş Ş; Nergizoğlu G
    J Clin Rheumatol; 2018 Aug; 24(5):290-291. PubMed ID: 29239931
    [No Abstract]   [Full Text] [Related]  

  • 43. Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation.
    Alejandre N; Ruiz-Palacios A; García-Aparicio AM; Blanco-Kelly F; Bermúdez S; Fernández-Sanz G; Romero FI; Aróstegui JI; Ayuso C; Jiménez-Alfaro I; Herrero-Beaumont G; Sánchez-Pernaute O
    Rheumatology (Oxford); 2014 Jun; 53(6):1095-9. PubMed ID: 24501247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome.
    Kuemmerle-Deschner JB; Tyrrell PN; Koetter I; Wittkowski H; Bialkowski A; Tzaribachev N; Lohse P; Koitchev A; Deuter C; Foell D; Benseler SM
    Arthritis Rheum; 2011 Mar; 63(3):840-9. PubMed ID: 21360513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy.
    Kim YH; Kim BJ; Han J; Choi BY; Lee S
    J Clin Immunol; 2021 Nov; 41(8):1936-1939. PubMed ID: 34346012
    [No Abstract]   [Full Text] [Related]  

  • 46. [Muckle-Wells syndrome: a rare periodic fever syndrome].
    Appels CW; Kloppenburg M
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1628-31. PubMed ID: 16901068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathophysiological mechanisms underlying cryopyrin-associated periodic syndromes: genetic and molecular basis and the inflammasome].
    Aróstegui JI
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():22-8. PubMed ID: 21596183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel mutation in the CIAS1/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes.
    Insalaco A; Prencipe G; Buonuomo PS; Ceccherini I; Bracaglia C; Pardeo M; Nicolai R; De Benedetti F
    Clin Exp Rheumatol; 2014; 32(1):123-5. PubMed ID: 24144430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy.
    Paloni G; Pastore S; Tommasini A; Lepore L; Taddio A
    Clin Exp Rheumatol; 2015; 33(5):766. PubMed ID: 26316056
    [No Abstract]   [Full Text] [Related]  

  • 50. Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra.
    Gerard S; le Goff B; Maugars Y; Berthelot JM; Malard O
    Joint Bone Spine; 2007 Dec; 74(6):659. PubMed ID: 17892965
    [No Abstract]   [Full Text] [Related]  

  • 51. Switch from anakinra to canakinumab in a severe case of CINCA syndrome.
    Rigante D; Verrecchia E; Falsini B; Manna R
    Int J Rheum Dis; 2016 Dec; 19(12):1354-1356. PubMed ID: 26585548
    [No Abstract]   [Full Text] [Related]  

  • 52. Cryopyrin-associated periodic syndromes and autoinflammation.
    Shinkai K; McCalmont TH; Leslie KS
    Clin Exp Dermatol; 2008 Jan; 33(1):1-9. PubMed ID: 17927785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases.
    Aróstegui JI; Lopez Saldaña MD; Pascal M; Clemente D; Aymerich M; Balaguer F; Goel A; Fournier del Castillo C; Rius J; Plaza S; López Robledillo JC; Juan M; Ibañez M; Yagüe J
    Arthritis Rheum; 2010 Apr; 62(4):1158-66. PubMed ID: 20131270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment.
    Boschan C; Witt O; Lohse P; Foeldvari I; Zappel H; Schweigerer L
    Am J Med Genet A; 2006 Apr; 140(8):883-6. PubMed ID: 16532456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CINCA syndrome with surgical intervention for valgus deformity and flexion contracture of the knee joint: A case report.
    Harada Y; Fukiage K; Nishikomori R; Suzuki S; Futami T
    Mod Rheumatol; 2017 Nov; 27(6):1098-1100. PubMed ID: 25867226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.
    Bozkurt Y; Demir A; Erman B; Gül A
    Comput Math Methods Med; 2015; 2015():893507. PubMed ID: 26161132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term treatment with anakinra and canakinumab resolves patellar subchondral erosion in neonatal-onset multisystem inflammatory disease.
    Leone A; Manna R; Verrecchia E; Cipullo M; Rigante D
    Reumatismo; 2019 Apr; 71(1):53-55. PubMed ID: 30932446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anakinra in mutation-negative NOMID/CINCA syndrome: comment on the articles by Hawkins et al and Hoffman and Patel.
    Frenkel J; Wulffraat NM; Kuis W
    Arthritis Rheum; 2004 Nov; 50(11):3738-9; author reply 3739-40. PubMed ID: 15529342
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.